Human EB-VCA-IgM (Epstein-barr virus capsid antigen-Immunoglobulin M) ELISA Kit (HUFI04705)

The Human EB-VCA-IgM ELISA kit from Assay Genie enables quantitative detection of IgM antibodies directed against the Epstein-Barr virus capsid antigen, supporting serological differentiation of acute versus past EBV infection. VCA-IgM seropositivity typically rises at clinical onset of infectious mononucleosis and declines within weeks to a few months, making this an informative early-stage marker. The kit is intended for in vitro research use and pairs with EBNA-1 IgG and EA-D IgG assays to resolve primary infection, reactivation, and past exposure patterns. Investigators studying EBV-linked conditions including nasopharyngeal carcinoma, Burkitt's lymphoma, Hodgkin lymphoma, and post-transplant lymphoproliferative disorder apply this capture antibody-based workflow to characterise immune status. Each well requires a sample volume of 50 uL, and unopened components should be refrigerated at 4 degrees C and protected from light to preserve reagent activity through the stated shelf life. Delivered as a complete kit containing a precoated microplate and ready-to-use buffers, the assay is restricted to research use only and is not intended for diagnostic or clinical decision-making.